Olivier Ziegler

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Luc F. Van Gaal, Aila Rissanen, André Scheen et al. · The Lancet · 2005 · 1.5K citations · Full text

Obesity, Metabolic Syndrome, Cannabis Use +10

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

M Apfelbaum, P Vague, Olivier Ziegler et al. · The American Journal of Medicine · 1999 · 348 citations

Obesity, Metabolic Syndrome, Nutrition +13

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Dietary Beliefs and Behavior Among Inflammatory Bowel Disease Patients

Camille Zallot, Didier Quilliot, Jean–Baptiste Chevaux et al. · Inflammatory Bowel Diseases · 2012 · 232 citations · Full text

TNFα up‐regulates apelin expression in human and mouse adipose tissue

Danièle Daviaud, Jérémie Boucher, Stéphane Gesta et al. · The FASEB Journal · 2006 · 214 citations

Metabolic Disorder, Molecular Regulation, Immunology +24